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differences in per session EPO dose were generally greater the longer the
episode. For missed session episodes with no additional misses in the 30
day before/after period, increases of 18% to 30% per session were seen,
depending on episode length. For longer episodes, usually due to
hospitalization, differences were sustained over 60 days. Analyses which
included additional missed sessions in the before/after period showed
similar patterns. Beyond these per-session associations, the total amount of
EPO used in a month increased with number of missed sessions (through
up to 5 missed sessions), even though these patients (by deﬁnition) were
not receiving as many administrations of EPO.
Missed session episodes result in signiﬁcant increases in ESA utilization
in the post-miss period, and also in total monthly ESA use. Such increases
should be considered in any assessment of impact of missed sessions: both
clinical and economic.
http://dx.doi.org/10.1016/j.krcp.2012.04.40582
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Hemodialysis (HD) patients are frequently hospitalized. Interruption of
normal dialysis and 3x/weekly ESA treatments, along with the cause of
hospitalization, normally leads to declines in Hb and increased ESA
utilization post-hospitalization.
In this retrospective analysis, we examined Hb levels and ESA use before
and after hospitalization in adult (Z18 yrs old) HD patients from 1/1/
2009-12/31/2010. Hospitalizations preceded by 4 30 hospital-free days
were included in the analysis.
Pre and post-hospitalization Hb test data was available for 156,353
events: 67.4% showed a drop in Hb levels in the 30 days after
hospitalization, 0.7% had no change and 32.7% exhibited a rise in Hb levels.
For patients with falling Hb, the mean level after hospitalization was
10.55 g/dL, compared to 11.87 g/dL before hospitalization, corresponding
to a mean drop of 1.32 g/dL (SD¼1.00). Mean monthly Hb levels for all
patients were 11.48 g/dL and 10.88 g/dL before and after hospitalization,
respectively.
ESA dose changes were assessed for 179,929 hospitalization events.
Analysis of ESA use over 30 days before/after hospitalization showed
increased epoetin alfa (EPO) use post-hospitalization in 60.8% of events,
4.9% showed no mean change, and 34.3% showed a drop in EPO use. Of the
hospitalizations with mean per-session increases in EPO, in 69.7% of events
the rise in EPO dose occurred before the ﬁrst post-hospitalization Hb test
result was known, and in 30.3% the increase occurred after Hb testing.
We found that hospitalizations frequently lead to a drop in patients’ Hb
levels and an increase in post-hospitalization EPO dose. However, EPO dose
increases often occur before post-hospitalization Hb levels are known.
Strategies for better management of anemia in the post-hospitalization
period should be assessed.
http://dx.doi.org/10.1016/j.krcp.2012.04.40683
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Purpuse: It has been postulated that ﬂuid overload and lipid metabolic
derangement is more common in peritoneal dialysis (PD) patients than in
hemodialysis (HD) patients. The purpose of this study was to evaluate the
differences in body composition in HD and PD patients.
Methods: We compared whole body composition using bioimpedence
analysis (BIA) in 14 hemodialysis patients and 14 peritoneal dialysis patients.
BIA was performed at 1, 3, 6, and 12 months after initiation of HD or PD
Results: Compared with HD patients, PD patients had a higher ratio of
extracellular ﬂuid/total body ﬂuid at 12 months (0.39 vs 0.34, po0.05) and a
lower level of serum albumin (3.6 g/dL vs. 3.9 g/dL, po0.05). There were no
differences in skeletal muscle mass, body fat mass, visceral fat area or serum
total cholesterol level between HD and PD patients.Conclusions: Extracellular ﬂuid overload and hypoalbuminemia were more
common in PD patients than in HD patients. Serial assessment andmonitoring
of nutrition and volume status are needed for early recognition and
management in these patients
http://dx.doi.org/10.1016/j.krcp.2012.04.40784
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It is possible to observe improvement in the general state of patients
receiving maintenance hemodialysis, including decreased joint symptoms,
decreased pruritus, and better appetite, by using a high-efﬁciency, high-ﬂux
dialysis membrane. We aimed to determine the effects of the use of a high-
ﬂux dialysis membrane on improvement in the nutritional status of dialysis
patients. Twomonths before the replacement with a high-efﬁciency, high-ﬂux
dialysis membrane and one, three, six, and twelve months after the
replacement, the subjective global assessment (SGA), biochemical markers,
and a Body Composition Analyzer was used to assess the nutritional status
and determine hemodialysis adequacy, along with a biochemical test, in 25
stable patients (M: F¼10:15, 54.5712.7 (3780) yrs). Of all the patients,
3 got better results from SGA, 12 the same results, and 10 worse results, in the
follow-up period. There was no signiﬁcant increase or decrease after the
replacement with a high-ﬂux dialysis membrane in biochemical parameters
and nutritional parameters. While there was also no improvement in body
weight, fat mass, muscle mass, lean fat mass, visceral fat, or the degree of
edema measured by the body composition analyzer after the replacement,
basal metabolism was improved from 1179.27143.5 kcal before the
replacement to 1264.87145.4, 12417138.3, and 1201.07317.0 kcal one,
three, twelve months after the replacement, respectively, on the average
(po0.001, p¼0.001, p¼0.023); thus, the improvement was greatest one
month after the replacement and, then, decreased over time. In conclusion,
the use of a high-efﬁciency, high-ﬂux dialysis membrane generally failed to
improve the nutritional status of patients receiving maintenance hemodialysis
but increased the indirect index of basal metabolism alone at its early stage.
http://dx.doi.org/10.1016/j.krcp.2012.04.40885
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There are few reports about therapeutic effects of low protein diet on the
progression of chronic renal failure due to autosomal dominant polycystic
kidney disease (ADPKD), although the disease is common.The annual
incidence rate for end-stage renal disease caused by ADPKD is around 6 per
million.In this retrospective study in one center, ten chronic renal failure
patients due to ADPKD with creatinine clearnce of 17.073.3 mL/min /
1.73 m2 and serum creatinine (Cr) level of 4.470.7 mg/dL were studied for
40 months after the introduction of severe low protein diet (SLPD)
(0.4870.03 g/kgBW/day) without supplementation of essential amino
acids or keto-analogues. Dietary protein intake was estimated by urea
appearance rate from 24hr urine sample according to Mitch-Maroni’s
formula. The results clearly showed that n1/Cr/month(103) was
signiﬁcantly suppressed from 5.870.9 to 2.070.6 following the
introduction of SLPD (po0.02). Furthermore, BUN/Cr ratio decreased from
10.470.02 to 7.370.02 (po0.01). Mean blood pressure (mmHg)
remained unchanged; 9273 vs 8973 (ns), and urinary protein excretion
(g/day) did not change; 0.670.2 vs 0.670.1 (ns). There were no signiﬁcant
differences between body mass index, serum albumin, transferrin and
hemoglobin levels as the indices of nutritional state before and after the
introduction of SLPD.In conclusion, SLPD was effective in suppressing the
progression of further decline in renal function due to ADPKD under
nutritionally safety condition in this cohort.
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